08-02-2018 11:28 AM CET - Health & Medicine

Bioimplants Market Research Report 2018-2023| Cardiovascular, Dental, Orthopedic, Spinal and Ophthalmology Bioimplants Forecast 2023

Press release from: Allied Market Research
Bioimplants Market
Bioimplants Market

"Bioimplants Market by Type, and Material: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period.

Access Full Report Summary: www.alliedmarketresearch.com/bioimplants-market

Bioimplant are devices of human or animal origin used to replace a missing natural body structure, support an injured biological part, or improve an existing biological structure. The major factors that contribute to the market growth include increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced treatment devices, and growth in awareness regarding both the disease and treatment devices available in the market. However, the stringent approval procedure of the bioimplant is expected to impede the market growth. In addition, significant unmet need in the emerging nations provides a lucrative opportunity for the market.

The orthopedic bioimplant segment generated the maximum revenue, accounting for nearly 40% of the global digital bioimplant market in 2016. On the other hand, dental bioimplant segment is expected to witness the highest CAGR during the forecast period.

By material, the metallic biomaterial segment is expected to dominate the market, accounting for nearly two-thirds share in 2023. On the other hand, the polymeric biomaterials segment is estimated to register the highest CAGR during the forecast period.

Key Findings of the Bioimplants Market:

•The cardiovascular bioimplant segment contributed for nearly one-fourth share of the global bioimplant market in 2016.
•The spinal bioimplant segment is projected to grow at a significant CAGR from 2017 to 2023.
•The natural biomaterial segment is projected to grow at a significant CAGR during the forecast period.
•Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe bioimplant market in 2016.
•Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific bioimplant market in 2016.

Download Full Sample Copy: www.alliedmarketresearch.com/request-sample/4652

Bioimplants Market Key Segments:

By Type

•Cardiovascular bioimplant
o Stent
 Coronary stent
 Drug-eluting stent (DES)
 Bare-metal coronary stent
 Bioabsorbable stent
 Peripheral stent
 Iliac
 Femoral-popliteal
 Renal
 Carotid
 Stent-related bioimplant
 Synthetic graft
 Vena Cava filter

o Pacing device
 Cardiac resynchronization therapy device (CRTs)
 Implantable cardioverter defibrillator (ICDs)
 Implantable cardiac pacemaker (ICPs)
o Structural Cardiac Implant

 Mechanical heart valve
 Implantable ventricular-assist device

•Dental bioimplant
o Plate form dental implant
o Root form dental implant

•Orthopedic bioimplant
o Reconstructive joint replacement
o Knee replacement implant
o Hip replacement implant
o Extremities
o Orthobiologics
o Trauma & craniomaxillofacial
•Spinal bioimplant
o Spinal fusion implant
o Spinal bone stimulator
o Vertebral compression fracture (VCF) device
o Motion preservation devices/non-fusion device
o Spine biologics
•Ophthalmology bioimplant
o Glaucoma implant
o Intraocular implant

By material
•Metallic biomaterial
•Ceramic biomaterial
•Polymers biomaterial
•Natural biomaterial

By Region
•North America

The North America market is projected to dominate the global bioimplant market in terms of revenue during the forecast period. This is majorly due to the increase in technological development and rise in incidence of cardiac, neuro, and spinal disorders. The Asia-Pacific market is expected to grow at the highest CAGR of 8.7% during the forecast period, owing to rise in awareness about the use of bio implants in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are Abbott Laboratories (St. Jude Medical, Inc.), Boston Scientific Corporation, Dentsply Sirona Inc., Johnson & Johnson (Ethicon, Inc.), Medtronic Plc, Smith & Nephew Plc, Stryker Corporation, Victrex Plc. (Invibio Ltd.), Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.

Enquiry and Purchase Report: www.alliedmarketresearch.com/purchase-enquiry/4652

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company implies the client’s insight into the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to aid the clients to turn into the prominent business firm.

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩-550-5975
Web: www.alliedmarketresearch.com

This release was published on openPR.
News-ID: 1158612 • Views: 473
More releases More releases

You can edit or delete your press release here: